These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3780114)

  • 1. Steady-state carbamazepine plasma concentration-dose ratios in epileptic patients.
    Sánchez A; Durán JA; Serrano JS
    Clin Pharmacokinet; 1986; 11(5):411-4. PubMed ID: 3780114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diurnal fluctuations in plasma carbamazepine level in children with epilepsy].
    Losiowski Z; Prokopczyk J; Zimak J; Bielicka J
    Neurol Neurochir Pol; 1988; 22(3):195-200. PubMed ID: 3221956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
    Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
    Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E; Kandil MR; Afifi AH; Mostafa OA
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum levels of vitamin B12 in epileptic patients treated with carbamazepine].
    Rościszewska D; Motta E; Guz I
    Neurol Neurochir Pol; 1993; 27(5):671-5. PubMed ID: 8114990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing plasma level/dose ratios of carbamazepine and its major metabolites in epileptic children.
    Hartley R; Lucock MD; Ng PC; Forsythe WI; McLain B; Bowmer CJ
    Ther Drug Monit; 1990 Sep; 12(5):438-44. PubMed ID: 2293405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy.
    Kumps AH
    Ther Drug Monit; 1981; 3(3):271-4. PubMed ID: 7324091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carbamazepine dosage and its blood serum level in children].
    Czochańska J; Losiowski Z; Prokopczyk J; Zimak J
    Neurol Neurochir Pol; 1987; 21(1):6-10. PubMed ID: 3614524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epoxide of carbamazepine.
    McKauge L; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1979; 16():95-104. PubMed ID: 550961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dose increments on serum carbamazepine concentration in epileptic patients.
    Perucca E; Bittencourt P; Richens A
    Clin Pharmacokinet; 1980; 5(6):576-82. PubMed ID: 7438655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy.
    Battino D; Bossi L; Croci D; Franceschetti S; Gomeni C; Moise A; Vitali A
    Ther Drug Monit; 1980; 2(4):315-22. PubMed ID: 7222185
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
    Wang RB; Liu LT; Yiu CH; Chang TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy].
    Sołowiej E; Sobaniec W
    Neurol Neurochir Pol; 2003; 37(5):991-1003. PubMed ID: 15174247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for carbamazepine elevation and toxicity following epilepsy surgery.
    Hiremath GK; Kotagal P; Bingaman W; Hovinga C; Wyllie E; Morris H; Nelson D
    Seizure; 2005 Jul; 14(5):312-7. PubMed ID: 15876544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
    El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
    J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
    Tomson T; Svensson JO; Hilton-Brown P
    Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration of carbamazepine in plasma during long term anti-epilepsy treatment].
    Gauchel FD; Holzbach E; Rabe F; Spancken E
    Bibl Psychiatr; 1975; (151):28-31. PubMed ID: 1156345
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.